55 related articles for article (PubMed ID: 16045749)
1. BCR kinase phosphorylates 14-3-3 Tau on residue 233.
Clokie SJ; Cheung KY; Mackie S; Marquez R; Peden AH; Aitken A
FEBS J; 2005 Aug; 272(15):3767-76. PubMed ID: 16045749
[TBL] [Abstract][Full Text] [Related]
2. Requirement of two specific tyrosine residues for the catalytic activity of Bcr serine/threonine kinase.
Wu Y; Liu J; Arlinghaus RB
Oncogene; 1998 Jan; 16(1):141-6. PubMed ID: 9467953
[TBL] [Abstract][Full Text] [Related]
3. B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.
Papin C; Eychène A; Brunet A; Pagès G; Pouysségur J; Calothy G; Barnier JV
Oncogene; 1995 Apr; 10(8):1647-51. PubMed ID: 7731720
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
[TBL] [Abstract][Full Text] [Related]
5. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD
Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226
[TBL] [Abstract][Full Text] [Related]
8. The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent manner.
Laurent CE; Smithgall TE
Exp Cell Res; 2004 Sep; 299(1):188-98. PubMed ID: 15302586
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase A phosphorylates and regulates dimerization of 14-3-3 epsilon.
Gu YM; Jin YH; Choi JK; Baek KH; Yeo CY; Lee KY
FEBS Lett; 2006 Jan; 580(1):305-10. PubMed ID: 16376338
[TBL] [Abstract][Full Text] [Related]
10. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
Nieborowska-Skorska M; Slupianek A; Skorski T
Oncogene; 2000 Aug; 19(36):4117-24. PubMed ID: 10962572
[TBL] [Abstract][Full Text] [Related]
11. Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold protein PDZK1 and vesicle coat protein Mint3.
Malmberg EK; Andersson CX; Gentzsch M; Chen JH; Mengos A; Cui L; Hansson GC; Riordan JR
J Cell Sci; 2004 Nov; 117(Pt 23):5535-41. PubMed ID: 15494376
[TBL] [Abstract][Full Text] [Related]
12. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
[TBL] [Abstract][Full Text] [Related]
13. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
Lionberger JM; Smithgall TE
Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
[TBL] [Abstract][Full Text] [Related]
14. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
Liu J; Wu Y; Arlinghaus RB
Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
[TBL] [Abstract][Full Text] [Related]
15. Bcr phosphorylated on tyrosine 177 binds Grb2.
Ma G; Lu D; Wu Y; Liu J; Arlinghaus RB
Oncogene; 1997 May; 14(19):2367-72. PubMed ID: 9178913
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
Beadling C; Ng J; Babbage JW; Cantrell DA
EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
[TBL] [Abstract][Full Text] [Related]
17. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
[TBL] [Abstract][Full Text] [Related]
18. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
Arlinghaus RB
Oncogene; 2002 Dec; 21(56):8560-7. PubMed ID: 12476302
[TBL] [Abstract][Full Text] [Related]
19. C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.
Skorski T; Nieborowska-Skorska M; Szczylik C; Kanakaraj P; Perrotti D; Zon G; Gewirtz A; Perussia B; Calabretta B
Cancer Res; 1995 Jun; 55(11):2275-8. PubMed ID: 7757976
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
Oncogene; 1997 Feb; 14(5):507-13. PubMed ID: 9053848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
